Marshall Wace
LKFT

Marshall Wace’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Marshall Wace’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,200
Closed -$366K – 3394
2025
Q4 		$366K Sell
11,200
-27,260
-71% -$880K ﹤0.01% 2376
2025
Q3 		$1.33M Buy
+38,460
New +$1.23M ﹤0.01% 1813
2024
Q3 		– Sell
-12,715
Closed -$315K – 2674
2024
Q2 		$315K Buy
+12,715
New +$361K ﹤0.01% 2130
2023
Q3 		– Sell
-43,615
Closed -$1.77M – 2380
2023
Q2 		$1.77M Buy
43,615
+30,776
+240% +$1.26M ﹤0.01% 1459
2023
Q1 		$496K Buy
+12,839
New +$528K ﹤0.01% 2102
2022
Q4 		– Sell
-17,149
Closed -$732K – 3113
2022
Q3 		$732K Buy
+17,149
New +$879K ﹤0.01% 2557
2022
Q1 		– Sell
-6,225
Closed -$344K – 3580
2021
Q4 		$344K Buy
+6,225
New +$325K ﹤0.01% 2975
2020
Q3 		– Sell
-4,772
Closed -$941K – 1708
2020
Q2 		$941K Buy
+4,772
New +$988K 0.01% 1012
2019
Q4 		– Sell
-1,732
Closed -$264K – 1838
2019
Q3 		$264K Buy
+1,732
New +$284K ﹤0.01% 1234
2019
Q2 		– Sell
-23,767
Closed -$2.8M – 1528
2019
Q1 		$2.8M Sell
23,767
-69,991
-75% -$7.06M 0.03% 646
2018
Q4 		$8.6M Sell
93,758
-42,494
-31% -$4.31M 0.09% 289
2018
Q3 		$15.3M Buy
+136,252
New +$14.4M 0.13% 211
2018
Q2 		– Sell
-42,649
Closed -$4.25M – 747
2018
Q1 		$4.25M Buy
+42,649
New +$4.6M 0.18% 116
2017
Q1 		– Sell
-7,340
Closed -$471K – 466
2016
Q4 		$471K Buy
7,340
+1,311
+22% +$80.7K ﹤0.01% 847
2016
Q3 		$390K Buy
+6,029
New +$340K ﹤0.01% 829

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
DCM
DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Marshall Wace's LKFT Position: Q1 2026 in Review

Marshall Wace sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2026, closing a stake of 11,200 shares — an estimated $366K sold.

Marshall Wace first reported a position in LKFT in Q3 2016 and held it in 15 quarters. The position peaked at $15.3M in Q3 2018. 90 funds tracked by Wall St. Rank hold LKFT as of Q1 2026.

  • Marshall Wace reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q1 2026 after selling out during the quarter.
  • Marshall Wace sold 11,200 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2026, an estimated $366K.
  • Marshall Wace first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q3 2016 and held it in 15 quarters.
  • Marshall Wace's Lakefront Biotherapeutics American Depositary Shares position peaked at $15.3M in Q3 2018.
  • 90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.